Dynamic Susceptibility Contrast-Enhanced Perfusion and Conventional MR Imaging Findings for Adult Patients with Cerebral Primitive Neuroectodermal Tumors

References

1. ↵
   Gaffney CC, Sloane JP, Bradley NJ, Bloom HJ. Primitive neuroectodermal tumors of the cerebrum: pathology and treatment. J Neurooncol 1985;3:23–33

   PubMed
2. ↵
   Masuda K, Yutani C, Akutagawa K, et al. Cerebral primitive neuroectodermal tumor in an adult male: a case report. Acta Cytol 2000;44:1050–1058

   PubMed
3. ↵
   Bellis EH, Salcman M, Bastian FO. Primitive neuroectodermal tumor in a 57-year-old man. Surg Neurol 1983;20:30–35

   CrossRefPubMed
4. Grant G, Pathak S, Maria BL. Identification of marker chromosomes in a human medulloblastoma cell line (D283 Med). Cancer Genet Cytogenet 1988;34:247–250

   CrossRefPubMedWeb of Science
5. ↵
   Kim DG, Lee DY, Paek SH, Chi JG, Choe G, Jung HW. Supratentorial primitive neuroectodermal tumors in adults. J Neurooncol 2002;60:43–52

   PubMed
6. ↵
   Pickuth D, Leutloff U. Computed tomography and magnetic resonance imaging findings in primitive neuroectodermal tumors in adults. Br J Radiol 1996;69:1–5

   Abstract/FREE Full Text
7. ↵
   Majos C, Alonso J, Aguilera C, et al. Adult primitive neuroectodermal tumor: proton MR spectroscopic findings with possible application for differential diagnosis. Radiology 2002;225:556–566

   PubMed
8. ↵
   Brandes AA, Palmisano V, Monfardini S. Medulloblastoma in adults: clinical characteristics and treatment. Cancer Treat Rev 1999;25:3–12

   CrossRefPubMed
9. ↵
   Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994;191:41–51

   PubMedWeb of Science
10. ↵
    Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D. Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 2002;223:11–29

    CrossRefPubMedWeb of Science
11. ↵
    Knopp EA, Cha S, Johnson G, et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999;211:791–798

    CrossRefPubMedWeb of Science
12. Lev MH, Rosen BR. Clinical applications of intracranial perfusion MR imaging. Neuroimaging Clin N Am 1999;9:309–331

    PubMedWeb of Science
13. Shin JH, Lee HK, Kwun BD, et al. Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results. AJR Am J Roentgenol 2002;179:783–789

    CrossRefPubMed
14. ↵
    Sugahara T, Korogi Y, Kochi M, et al. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol 1998;171:1479–1486

    CrossRefPubMedWeb of Science
15. ↵
    Provenzale JM, Wang GR, Brenner T, Petrella JR, Sorensen AG. Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. AJR Am J Roentgenol 2002;178:711–716

    CrossRefPubMedWeb of Science
16. Roberts HC, Roberts TP, Ley S, Dillon WP, Brasch RC. Quantitative estimation of microvascular permeability in human brain tumors: correlation of dynamic Gd-DTPA-enhanced MR imaging with histopathologic grading. Acad Radiol 2002;9[suppl 1]:S151–S155
17. ↵
    Uematsu H, Maeda M, Sadato N, et al. Vascular permeability: quantitative measurement with double-echo dynamic MR imaging: theory and clinical application. Radiology 2000;214:912–917

    PubMed
18. ↵
    Kiessling F, Krix M, Heilmann M, et al. Comparing dynamic parameters of tumor vascularization in nude mice revealed by magnetic resonance imaging and contrast-enhanced intermittent power Doppler sonography. Invest Radiol 2003;38:516–524

    CrossRefPubMedWeb of Science
19. Bogin L, Margalit R, Mispelter J, Degani H. Parametric imaging of tumor perfusion using flow- and permeability-limited tracers. J Magn Reson Imaging 2002;16:289–299

    CrossRefPubMed
20. ↵
    Marzola P, Farace P, Calderan L, et al. In vivo mapping of fractional plasma volume (fpv) and endothelial transfer coefficient (Kps) in solid tumors using a macromolecular contrast agent: correlation with histology and ultrastructure. Int J Cancer 2003;104:462–468

    CrossRefPubMedWeb of Science
21. ↵
    Christoforidis GA, Grecula JC, Newton HB, et al. Visualization of microvascularity in glioblastoma multiforme with 8-T high-spatial-resolution MR imaging. AJNR Am J Neuroradiol 2002;23:1553–1556

    Abstract/FREE Full Text
22. ↵
    Christoforidis GA, Bourekas EC, Baujan M, et al. High resolution MRI of the deep brain vascular anatomy at 8 Tesla: susceptibility-based enhancement of the venous structures. J Comput Assist Tomogr 1999;23:857–866

    CrossRefPubMedWeb of Science
23. ↵
    Kleihues P, Soylemezoglu F, Schauble B, Scheithauer BW, Burger PC. Histopathology, classification, and grading of gliomas. Glia 1995;15:211–221

    CrossRefPubMedWeb of Science
24. ↵
    Rosen BR, Belliveau JW, Vevea JM, Brady TJ. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990;14:249–265

    PubMedWeb of Science
25. ↵
    Wetzel SG, Cha S, Johnson G, et al. Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study. Radiology 2002;224:797–803

    CrossRefPubMedWeb of Science
26. ↵
    Johnson G, Wetzel S, Cha S, Babb J, Tofts PS. Measuring blood volume and vascular transfer constant by dynamic T2*-weighted contrast-enhanced MRI. Magn Reson Med 2004;51 . In press
27. ↵
    Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging: fundamental concepts. Magn Reson Med 1991;17:357–367

    CrossRefPubMedWeb of Science
28. ↵
    Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999;10:223–232

    CrossRefPubMedWeb of Science
29. ↵
    Paulino AC, Melian E. Medulloblastoma and supratentorial primitive neuroectodermal tumors: an institutional experience. Cancer 1999;86:142–148

    PubMed
30. ↵
    Shimada H, Umehara S, Monobe Y, et al. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors. Cancer 2001;92:2451–2461

    CrossRefPubMedWeb of Science
31. ↵
    Saran F. Recent advances in pediatric neuro-oncology. Curr Opin Neurol 2002;15:671–677

    CrossRefPubMedWeb of Science
32. ↵
    Burger PC, Vogel FS. The brain: tumors. In: Burger PC, Vogel FS, eds. Surgical Pathology of the Central Nervous System and Its Coverings. New York: Wiley;1982 :223–266
33. ↵
    Hart MN, Earle KM. Primitive neuroectodermal tumors of the brain in children. Cancer 1973;32:890–897

    CrossRefPubMedWeb of Science
34. Kosnik EJ, Boesel CP, Bay J, Sayers MP. Primitive neuroectodermal tumors of the central nervous system in children. J Neurosurg 1978;48:741–746

    PubMedWeb of Science
35. ↵
    Duffner PK, Cohen ME, Heffner RR, Freeman AI. Primitive neuroectodermal tumors of childhood: an approach to therapy. J Neurosurg 1981;55:376–381

    PubMedWeb of Science
36. ↵
    Erdem E, Zimmerman RA, Haselgrove JC, Bilaniuk LT, Hunter JV. Diffusion-weighted imaging and fluid attenuated inversion recovery imaging in the evaluation of primitive neuroectodermal tumors. Neuroradiology 2001;43:927–933

    CrossRefPubMedWeb of Science
37. ↵
    Figeroa RE, el Gammal T, Brooks BS, Holgate R, Miller W. MR findings on primitive neuroectodermal tumors. J Comput Assist Tomogr 1989;13:773–778

    PubMed
38. ↵
    Zagzag D, Miller DC, Knopp EA, et al. Primitive neuroectodermal tumors of the brainstem: investigation of seven cases. Pediatrics 2000;106:1045–1053

    Abstract/FREE Full Text
39. ↵
    Osborn AG. Diagnostic Neuroradiology. St. Louis: Mosby;1994
40. ↵
    Cha S, Johnson G, Wadghiri YZ, et al. Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: correlation with histopathology. Magn Reson Med 2003;49:848–855

    CrossRefPubMedWeb of Science
41. ↵
    Roberts HC, Roberts TPL, Brasch RC, Dillon WP. Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. AJNR Am J Neuroradiol 2000;21:891–899

    Abstract/FREE Full Text
42. ↵
    Rydland J, BjOrnerud A, Haugen O, et al. New intravascular contrast agent applied to dynamic contrast enhanced MR imaging of human breast cancer. Acta Radiol 2003;44:275–283

    CrossRefPubMedWeb of Science
43. ↵
    Brem S. Angiogenesis and cancer control: from concept to therapeutic trial. Cancer Control 1999;6:436–458

    PubMed
44. ↵
    Daumas-Duport C, Scheithauer B, O’Fallon J, Kelly P. Grading of astrocytomas: a simple and reproducible method. Cancer 1988;62:2152–2165

    CrossRefPubMedWeb of Science
45. ↵
    Cha S, Pierce S, Knopp EA, et al. Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions. AJNR Am J Neuroradiol 2001;22:1109–1116

    Abstract/FREE Full Text
46. ↵
    Hartmann M, Heiland S, Harting I, et al. Distinguishing of primary cerebral lymphoma from high-grade glioma with perfusion-weighted magnetic resonance imaging. Neurosci Lett 2003;338:119–122

    CrossRefPubMedWeb of Science
47. Law M, Teicher N, Zagzag D, Knopp EA. Dynamic contrast enhanced perfusion MRI in mycosis fungoides. J Magn Reson Imaging 2003;18:364–367

    CrossRefPubMed
48. ↵
    Sugahara T, Korogi Y, Shigematsu Y, et al. Perfusion-sensitive MRI of cerebral lymphomas: a preliminary report. J Comput Assist Tomogr 1999;23:232–237

    CrossRefPubMed
49. ↵
    McDonald DM, Choyke PL. Imaging of angiogenesis: from microscope to clinic. Nat Med 2003;9:713–725

    CrossRefPubMedWeb of Science
50. ↵
    Vajkoczy P, Menger MD. Vascular microenvironment in gliomas. J Neurooncol 2000;50:99–108

    CrossRefPubMed
51. ↵
    Li KL, Zhu XP, Checkley DR, et al. Simultaneous mapping of blood volume and endothelial permeability surface area product in gliomas using iteractive analysis of first-pass dynamic contrast enhanced MRI data. Br J Radiol 2003;76:39–51

    Abstract/FREE Full Text
52. ↵
    McDonald DM, Baluk P. Significance of blood vessel leakiness in cancer. Cancer Res 2002;62:5381–5385

    Abstract/FREE Full Text
53. ↵
    Cha S, Lu S, Johnson G, Knopp EA. Dynamic susceptibility contrast MR imaging: correlation of signal intensity changes with cerebral blood volume measurements. J Magn Reson Imaging 2000;11:114–119

    CrossRefPubMed
54. ↵
    Bhujwalla ZM, Artemov D, Natarajan K, Solaiyappan M, Kollars P, Kristjansen PE. Reduction of vascular and permeable regions in solid tumors detected by macromolecular contrast magnetic resonance imaging after treatment with antiangiogenic agent TNP-470. Clin Cancer Res 2003;9:355–362

    Abstract/FREE Full Text
55. ↵
    Degani H, Chetrit-Dadiani M, Bogin L, Furman-Haran E. Magnetic resonance imaging of tumor vasculature. Thromb Haemost 2003;89:23–33